All articles by Joshi Kalyan
FDA clears Verily’s Study Watch for ECG
The FDA-approved Study Watch is a prescription-only device aimed to record, store, transfer and display single-channel ECG rhythms. It is…
World’s first diagnostic saliva test launched for malaria
Erada, which was founded by Benji Pretorius and Richard Schmidt, is situated in Musina, South Africa. The alliance will market…
Titan Medical extends global patent portfolio for single-port robotic surgery
Including these new patents and notices, the Company has 28 issued patents and 70 pending patent applications in the U.S.,…
Garmin, ActiGraph partner on wearable-focused medical research
The partnership between Garmin International and ActiGraph will explore the creation of new health and activity monitoring solutions. The solutions…
Medtronic’s drug-coated balloon remains superior to PTA at five years
The data presented by the company reinforces the durability, safety, and effectiveness of the IN.PACT Admiral drug-coated balloon in patients…
Pulse Biosciences starts NPS cutaneous wart feasibility study
Pulse Biosciences said the feasibility study will include up to 20 subjects at the Scripps Clinic in San Diego, California,…
Johnson & Johnson Medical acquires Emerging Implant Technologies
Based in Wurmlingen, Germany, Emerging Implant Technologies (EIT) is a privately held manufacturer of 3D-printed titanium interbody implants for spinal…
FDA approves Masimo’s rainbow acoustic monitoring RAS-45 sensor for infant patients
Earlier, only patients over 10 kilograms were eligible for RAM sensors, but wit the new clearance acoustic respiration rate measurement…
Philips introduces updated TissueMark software to improve accuracy of tumor estimation
The new version, which will be showcased at the 30th European Congress of Pathology (ECP) 2018, from 8-12 September at…
EyeGate’s EGP-437 fails to demonstrate non-inferiority to control group
The treatment, delivered via the EyeGate II drug delivery system, showed clinical efficacy in reducing anterior chamber cell score but…